Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. - Walz JS; Kowalewski DJ; Backert L; Nelde A; Kohlbacher O; Weide B; Kanz L; Salih HR; Rammensee HG; Stevanović S (Leukemia & lymphoma, 2018)